Form 4 for RNXT RenovoRx, Inc.
Accepted 2025-05-06 00:00:00 ET · period of report 2025-05-02 · accession 0001641172-25-008842 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-06 | 2025-05-02 | RNXT | Marton Laurence | Dir | M - OptEx | $0.15 | +20.5K | 66.2K | +45% | +$3,072 |
| D | 2025-05-06 | 2025-05-02 | RNXT | Marton Laurence | Dir | M - OptEx | $0.00 | -20.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-02 | M | A | 20,480 | $0.15 | 66,164 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-05-02 | M | D | 20,480 | $0.00 | 0 | D | $0.15 · — to 2025-10-14 | 20,480 Common Stock | (F2) Shares subject to the option are fully vested and immediately exercisable. |